SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Units of beneficial interest

The QQQ is facing heightened volatility as market participants react to geopolitical tensions in the Middle East and concerns over prolonged military conflict, despite conflicting messaging regarding the status of the war. Community sentiment is deeply divided, with traders closely monitoring potential ground operations and energy sector impacts, while debates persist over the predictability of policy-driven market swings.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is experiencing significant volatility driven by market frustration over a presidential address that offered no clear de-escalation in the Iran conflict, sparking fears of a prolonged war and rising oil prices. Investors are expressing intense skepticism regarding leadership transparency and market manipulation, with community sentiment shifting heavily toward risk-off behavior ahead of the long weekend.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is gaining momentum as investors weigh a major deal to repurchase its Ireland-based manufacturing stake, signaling a strategic focus on regaining full control of its production capacity. Community discussion is polarized between bullish sentiment regarding long-term foundry turnaround potential and concerns over macro-volatility, sector-wide sell-offs, and exposure to geopolitical risks.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending following reports that Amazon is in advanced talks to acquire the company, fueling speculation of a potential bidding war with SpaceX to secure critical L-band and S-band spectrum for satellite-to-device connectivity. The community is actively debating the valuation, the strategic role of Apple's existing partnership, and the broader implications for the satellite internet race.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors aggressively position for the upcoming Artemis II mission and broader anticipation of a potential SpaceX IPO. While the stock has faced recent volatility from institutional selling registrations, the community remains intensely focused on the company's role in lunar infrastructure and its status as a key play in the evolving space economy.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG is gaining massive momentum across social media following its recent listing on Coinbase, fueling community excitement about its potential to challenge established meme coins. Investors are highlighting the asset's fixed supply and native Bitcoin security as key fundamentals, with many actively coordinating to drive awareness and adoption for the upcoming market cycle.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing heightened volatility and intense social media debate as investors weigh the impact of shifting geopolitical tensions, mixed signals on EV demand, and the looming SpaceX IPO. The stock is a primary focus for traders anticipating a sentiment reset ahead of quarterly production and delivery figures, with community discourse sharply divided between fundamental skepticism and speculative enthusiasm for the Musk-led ecosystem.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing heightened volatility and intense community debate as the stock navigates a mix of positive contract expansions, such as the Stellantis partnership, and significant headline risk regarding ethical concerns in data governance. Traders and investors are actively clashing over whether the current pullback represents a strategic buying opportunity for a long-term AI play or a broader structural shift away from high-valuation software growth.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging due to significant short-squeeze dynamics, an extremely high cost-to-borrow, and a robust quarterly revenue growth announcement. Investors are actively debating the stock's role as a natural gas provider amidst broader energy sector volatility and ongoing geopolitical tensions in the Middle East.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as traders weigh geopolitical instability in the Middle East against speculative optimism following government signals of potential de-escalation. Community sentiment is deeply divided, with many debating whether the stock's recent movements are a sustainable recovery or a "bull trap" driven by manipulation and unsustainable reliance on political news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going On With Structure Therapeutics Stock On Wednesday?

Structure Therapeutics shares rose, likely driven by FDA approval of a competing obesity treatment, boosting sentiment.read more...

<ul class="summary-bullets"><li>Earlier this month, Viking announced competition for patient enrollment in its late-stage clinical trial of subcutaneous VK2735, the company's experimental drug for weight loss.</li><li>Structure Therapeutics expects to initiate late-stage clinical development of its experimental drug Aleniglipron in the second half of 2026.</li><li>According to data from Koyfin, GPCR stock carries a 12-month average target of $109, while VKTX stock carries a 12-month average target of $92.72.</li></ul>Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are capturing intense investor attention as obesity treatments are increasingly deemed the largest growth engine in the U.S. pharmaceutical industry.Eli Lilly (LLY) and Novo Nordisk (NVO) currently dominate the current obesity drug market. Smaller firms Viking and Structure are both developing drugs for obesity even as bigger names like Pfizer (PFE) and AstraZeneca (AZN) also seek to enter the competition ring.<h2 class="st-heading-2">Viking, Structure’s Obesity Pipelines</h2>Earlier this month, Viking announced competition for patient enrollment in its late-stage clinical trial of subcutaneous VK2735, the company's experimental drug for weight loss. The trial enrolled about 1,000 patients with type 2 diabetes and who have obesity or who are overweight, the company said.The primary endpoint of the study is the percent change in body weight from baseline after 78 weeks of treatment for participants receiving VK2735 as compared to placebo. In a mid-stage trial, patients achieved up to 14.7% mean weight loss in 13 weeks on the drug.The dual agonist VK2735 is being developed in both oral and subcutaneous formulations. Viking is now looking forward to advancing the oral version of its experimental obesity drug into late-stage study in the third-quarter (Q3) of 2026.Meanwhile, Structure said earlier this month that its experimental drug Aleniglipron achieved clinically meaningful and statistically significant placebo-adjusted mean weight loss of 16.3% at the 180 mg dose and 16.0% at the 240 mg dose at 44 weeks in a mid-stage trial. The company now expects to initiate late-stage clinical development of the drug in the second half of 2026.The company also has other investigational obesity drugs called ACCG-2671 and ANPA-0073 currently in early stage studies. &nbsp;<h2 class="st-heading-2">Who Offers Better Upside?</h2>According to data from Koyfin, GPCR carries a 12-month average target of $109, implying a 147.95% upside potential from its last close. The stock holds a consensus analyst rating of 'Strong Buy', with 15 analysts rating the stock ‘Buy’ or higher while one rates it a ‘Hold’.Meanwhile, VKTX carries a 12-month average target of $92.72, representing a 209.80% upside from current levels. The stock also holds a consensus 'Strong Buy' rating, with 17 analysts rating it ‘Buy’ or higher while two hate it ‘Hold’.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment toward VKTX stock stayed within the ‘neutral’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.Meanwhile, sentiment toward GPCR stock stayed within the ‘bearish’ territory, while message volume fell from ‘normal’ to ‘low’ levels. &nbsp;<a href="https://stocktwits.com/symbol/VKTX">VKTX stock</a> has climbed 24% this year, while <a href="https://stocktwits.com/symbol/GPCR">GPCR</a> surged 154%.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/gm-doubles-down-on-heavy-duty-gas-trucks-amid-massive-ev-writedowns-report/cZERzvHRINm">GM Doubles Down On Heavy-Duty Gas Trucks Amid Massive EV Writedowns: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Injections for weight loss with Semaglutide. An obese woman gives a hormone glucagon-like peptide-1 (GLP-1) injection into the abdomen with a pen syringe.

VKTX Vs. GPCR: Which Obesity Drug Developer Does Wall Street See With The Bigger Upside?

According to analyst valuations, Structure Therapeutics may offer 148% potential upside, compared to an upside of 210% on Viking Therapeutics. 

Equity

According to analyst valuations, Structure Therapeutics may offer 148% potential upside, compared to an upside of 210% on Viking Therapeutics. 


Structure Therapeutics (NASDAQ:GPCR) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded shares of Structure Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Structure Therapeutics (NASDAQ:GPCR) Coverage Initiated by Analysts at Wolfe Research

Wolfe Research initiated coverage on shares of Structure Therapeutics in a report on Thursday. They issued a "peer perform" rating on the stock...

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Novo Nordisk faces slowing growth and rising competition, while Structure Therapeutics shows strong obesity study results, highlighting a clash of stability vs. upside.

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges

Key PointsB Group acquired 90,000 shares of Structure Therapeutics in the fourth quarter...

Structure Therapeutics (NASDAQ:GPCR) Shares Down 7.5% - Should You Sell?

Structure Therapeutics (NASDAQ:GPCR) Trading Down 7.5% - Should You Sell...

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

LLY stock falls 6% after an HSBC downgrade flagged persisting U.S. pricing pressure, rising market competition and compounded tirzepatide risks, despite strong GLP-1 demand.

What is HC Wainwright's Forecast for GPCR FY2027 Earnings?

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) - Stock analysts at HC Wainwright lifted their FY2027 earnings per share (EPS) estimates for Structure Therapeutics in a report...

Structure Therapeutics Posts 15%+ Weight Loss in ACCESS II for Oral GLP-1 Aleniglipron, Eyes Phase III

Structure Therapeutics (NASDAQ:GPCR) shared new top-line results from its ACCESS II clinical program for aleniglipron, an oral small-molecule GLP-1 receptor agonist being developed for chronic weight...

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

GPCR
Structure Therapeutics Inc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GPCR News

GPCRStructure Therapeutics Inc - ADR